Webster Stephen W — SEC Form 4 filings
SEC reporting owner CIK 1438421. 10 Form 4 filings on record with FilingPulse; latest filed 2026-06-22.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-04-30 to 2026-06-22. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 12.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Gritstone bio, Inc. (GRTS) | Director | 3 | — | — | 5 |
| Cullinan Therapeutics, Inc. (CGEM) | Director | 3 | — | — | 3 |
| NextCure, Inc. (NXTC) | Director | 3 | — | — | 3 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | Director | 1 | — | — | 1 |
Form 4 filings — Webster Stephen W
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-22 | 4 | NextCure, Inc. (NXTC) | Grant/award (A): 2,340 (derivative) @ $0 | EDGAR |
| 2026-06-18 | 4 | Cullinan Therapeutics, Inc. (CGEM) | Grant/award (A): 25,319 (derivative) @ $0 | EDGAR |
| 2026-06-10 | 4 | Eloxx Pharmaceuticals, Inc. (ELOX) | Grant/award (A): 13,587 (derivative) @ $0 | EDGAR |
| 2025-06-24 | 4 | NextCure, Inc. (NXTC) | Grant/award (A): 18,700 (derivative) @ $0 | EDGAR |
| 2025-06-16 | 4 | Cullinan Therapeutics, Inc. (CGEM) | Grant/award (A): 38,513 (derivative) @ $0 | EDGAR |
| 2025-04-08 | 4 | Gritstone bio, Inc. (GRTS) | Other (J): 25,000 @ $0 · Other (J): 103,600 (derivative) @ $0 · Other (J): 7,379 (derivative) @ $0 | EDGAR |
| 2024-06-27 | 4 | Cullinan Therapeutics, Inc. (CGEM) | Grant/award (A): 15,806 (derivative) @ $0 | EDGAR |
| 2024-06-21 | 4 | NextCure, Inc. (NXTC) | Grant/award (A): 18,700 (derivative) @ $0 | EDGAR |
| 2024-06-20 | 4 | Gritstone bio, Inc. (GRTS) | Grant/award (A): 7,379 (derivative) @ $0 | EDGAR |
| 2024-04-30 | 4 | Gritstone bio, Inc. (GRTS) | Grant/award (A): 103,600 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1438421 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →